Bio Protocol vs Zircuit — how do they compare? Bio Protocol trades at Rp515.13 (market cap Rp1,15T, Rp256,3M 24h volume), while Zircuit trades at Rp18.52 (market cap Rp113,72M, Rp48,13M 24h volume). The key difference: Bio Protocol is far larger — about 10112.6× Zircuit's market cap, and Bio Protocol's supply is capped (2,2B / 3,3B BIO (68%)) while Zircuit's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Zircuit for 13 Days on average.
| BIO | ZRC | |
|---|---|---|
Market Cap | Rp1,15T | Rp113,72M |
Volume (24h) | Rp256,3M | Rp48,13M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 5,9B ZRC |
Typical Hold Time | 16 Days | 13 Days |
What Pluang investors did over the last 30 days
No sentiment data available yet.
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Zircuit is an AI-powered blockchain designed for secure and automated financial transactions. As a fully EVM-compatible zero-knowledge rollup, Zircuit integrates advanced AI, zero-knowledge proofs, and a robust infrastructure to provide exceptional safety, performance, and scalability. Every transaction is secured at the sequencer level by AI models, ensuring a highly safe environment for both users and developers. Tailored for internet-scale applications, Zircuit reduces gas fees and enhances transaction speed, enabling the full potential of Web3 while maintaining comprehensive protection.
Read more on ZRC →